Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Factors Associated With the Poor Outcomes in Diabetic Patients With Covid-19 Publisher



Rastad H1 ; Ejtahed HS2, 3 ; Mahdavighorabi A4 ; Arzaghi M5 ; Safari A6 ; Shahrestanaki E6 ; Rezaei M7 ; Niksima MM7 ; Zakani A8 ; Dehghan Manshadi SH7 ; Ochi F7 ; Saedi S7 ; Khodaparast Z9 ; Shafiabadi Hassani N10 Show All Authors
Authors
  1. Rastad H1
  2. Ejtahed HS2, 3
  3. Mahdavighorabi A4
  4. Arzaghi M5
  5. Safari A6
  6. Shahrestanaki E6
  7. Rezaei M7
  8. Niksima MM7
  9. Zakani A8
  10. Dehghan Manshadi SH7
  11. Ochi F7
  12. Saedi S7
  13. Khodaparast Z9
  14. Shafiabadi Hassani N10
  15. Azimzadeh M11
  16. Qorbani M11, 12
Show Affiliations
Authors Affiliations
  1. 1. Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Basic and Clinical Research, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, Iran
  7. 7. Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran
  8. 8. Clinical Research Development Center of Rajaei, Alborz University of Medical Sciences, Karaj, Iran
  9. 9. Clinical Research Development Center of Kamali Hospital, Alborz University of Medical Sciences, Karaj, Iran
  10. 10. Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran
  11. 11. Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  12. 12. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2020


Abstract

Purpose: Diabetic’s patients are supposed to experience higher rates of COVID-19 related poor outcomes. We aimed to determine factors predicting poor outcomes in hospitalized diabetic patients with COVID-19. Methods: This retrospective cohort study included all adult diabetic patients with radiological or laboratory confirmed COVID-19 who hospitalized between 20 February 2020 and 27 April 2020 in Alborz province, Iran. Data on demographic, medical history, and laboratory test at presentation were obtained from electronic medical records. Diagnosis of diabetes mellitus was self-reported. Comorbidities including cancer, rheumatism, immunodeficiency, or chronic diseases of respiratory, liver, and blood were classified as “other comorbidities” due to low frequency. The assessed poor outcomes were in-hospital mortality, need to ICU care, and receiving invasive mechanical ventilation. Self-reported. Multivariate logistic regression models were fitted to quantify the predictors of in-hospital mortality from COVID-19 in patients with DM. Results: Of 455 included patients, 98(21.5%) received ICU care, 65(14.3%) required invasive mechanical ventilation, and 79 (17.4%) dead. In the multivariate model, significant predictors of “death of COVID-19” were age 65 years or older (OR (95% CI): 2.0 (1.16–3.44), chronic kidney disease (CKD) (2.05 (1.16–3.62), presence of “other comorbidities” (2.20 (1.04–4.63)), neutrophil count ≥8.0 × 109/L)6.62 (3.73–11.7 ((, Hb level < 12.5 g/dl (2.05 (1.13–3.72) (, and creatinine level ≥ 1.36 mg/dl (3.10 (1.38–6.98)). (All p –values <0.05). Some of these factors were also associated with other assessed poor outcomes, e.g., need to ICU care or invasive mechanical ventilation. Conclusion: Diabetic patients with age 65 years or older, comorbidity CKD, “other comorbidities”, as well as neutrophil count ≥8.0 × 109/L, Hb level < 12.5 g/dl, and creatinine level ≥ 1.36 mg/dl, were more likely to dead after COVID-19. Presence of hypertension and cardiovascular disease were associated with none of the poor outcomes. © 2020, Springer Nature Switzerland AG.
Other Related Docs
13. Analyzing Trends in Demographic, Laboratory, Imaging, and Clinical Outcomes of Icu-Hospitalized Covid-19 Patients, Canadian Journal of Infectious Diseases and Medical Microbiology (2023)
17. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
23. Variable Clinical Manifestations of Covid-19: Viral and Human Genomes Talk, Iranian Journal of Allergy# Asthma and Immunology (2020)
39. Nsaids and Covid-19: A New Challenging Area, Pharmaceutical Sciences (2020)
40. Covid-19 in Patients With Diabetes: Factors Associated With Worse Outcomes, Journal of Diabetes and Metabolic Disorders (2021)
44. Coagulopathy: Another Side Effect of Coronavirus Infection, Journal of Cardiovascular and Thoracic Research (2021)